Literature DB >> 17031708

Adderall produces increased striatal dopamine release and a prolonged time course compared to amphetamine isomers.

B Matthew Joyce1, Paul E A Glaser, Greg A Gerhardt.   

Abstract

RATIONALE: Adderall is currently used for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD) and is composed of a novel mixture of approximately 24% L-amphetamine and 76% D-amphetamine salts. There are, however, no investigations of the pharmacological effects of this combination in vivo.
OBJECTIVES: The technique of high-speed chronoamperometry using Nafion-coated single carbon-fiber microelectrodes was used to study amphetamine-evoked dopamine (DA) release produced by Adderall, D-amphetamine, or D,L-amphetamine in the striatum of anesthetized male Fischer 344 (F344) rats. The amphetamine solutions were locally applied from micropipettes by pressure ejection.
RESULTS: Local applications of Adderall resulted in significantly greater DA release signal amplitudes with prolonged time course of dopamine release and re-uptake as compared to D-amphetamine and D,L-amphetamine.
CONCLUSIONS: These data support the hypothesis that the combination of amphetamine enantiomers and salts in Adderall has effects on DA release, which result in increased and prolonged DA release, compared to D- and D,L-amphetamine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17031708     DOI: 10.1007/s00213-006-0550-9

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  50 in total

1.  Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats.

Authors:  E Carboni; A Imperato; L Perezzani; G Di Chiara
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

2.  Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation.

Authors:  L'aurelle A Johnson; Cheryse A Furman; Minjia Zhang; Bipasha Guptaroy; Margaret E Gnegy
Journal:  Neuropharmacology       Date:  2005-10-05       Impact factor: 5.250

Review 3.  Amphetamine: effects on catecholamine systems and behavior.

Authors:  L S Seiden; K E Sabol; G A Ricaurte
Journal:  Annu Rev Pharmacol Toxicol       Date:  1993       Impact factor: 13.820

4.  Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine.

Authors:  R Kuczenski; D S Segal
Journal:  J Pharmacol Exp Ther       Date:  2001-03       Impact factor: 4.030

Review 5.  Rapid regulation of the dopamine transporter: role in stimulant addiction?

Authors:  Nancy R Zahniser; Alexander Sorkin
Journal:  Neuropharmacology       Date:  2004       Impact factor: 5.250

6.  In vivo assessment of striatal dopamine release in the aged male Fischer 344 rat.

Authors:  H Kametani; S Iijima; E L Spangler; D K Ingram; J A Joseph
Journal:  Neurobiol Aging       Date:  1995 Jul-Aug       Impact factor: 4.673

7.  Regional studies of catecholamines in the rat brain. IV. Effects of drugs on the disposition and metabolism of H3-norepinephrine and H3-dopamine.

Authors:  J Glowinski; J Axelrod; L L Iversen
Journal:  J Pharmacol Exp Ther       Date:  1966-07       Impact factor: 4.030

8.  Amphetamine regulation of dopamine transport. Combined measurements of transporter currents and transporter imaging support the endocytosis of an active carrier.

Authors:  Kristopher M Kahlig; Jonathan A Javitch; Aurelio Galli
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

9.  Prenatal cocaine exposure alters potassium-evoked dopamine release dynamics in rat striatum.

Authors:  M F Salvatore; O Hudspeth; L E Arnold; P E Wilson; J A Stanford; C F MacTutus; R M Booze; G A Gerhardt
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

10.  Age-related changes in the capacity, rate, and modulation of dopamine uptake within the striatum and nucleus accumbens of Fischer 344 rats: an in vivo electrochemical study.

Authors:  M A Hebert; G A Gerhardt
Journal:  J Pharmacol Exp Ther       Date:  1999-02       Impact factor: 4.030

View more
  12 in total

1.  A review of long-acting medications for ADHD in Canada.

Authors:  Sheik Hosenbocus; Raj Chahal
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2009-11

Review 2.  The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities.

Authors:  Stephen V Faraone
Journal:  Neurosci Biobehav Rev       Date:  2018-02-08       Impact factor: 8.989

Review 3.  Assessment of potential cardiovascular risks of methylphenidate in comparison with sibutramine: do we need a SCOUT (trial)?

Authors:  Jochen Antel; Özgür Albayrak; Gerd Heusch; Tobias Banaschewski; Johannes Hebebrand
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-23       Impact factor: 5.270

4.  Novel multifunctional pharmacology of lobinaline, the major alkaloid from Lobelia cardinalis.

Authors:  Dustin P Brown; Dennis T Rogers; Francois Pomerleau; Kirin B Siripurapu; Manish Kulshrestha; Greg A Gerhardt; John M Littleton
Journal:  Fitoterapia       Date:  2016-04-20       Impact factor: 2.882

5.  Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo.

Authors:  J Shawn Goodwin; Gaynor A Larson; Jarod Swant; Namita Sen; Jonathan A Javitch; Nancy R Zahniser; Louis J De Felice; Habibeh Khoshbouei
Journal:  J Biol Chem       Date:  2008-12-01       Impact factor: 5.157

6.  The spontaneously hypertensive and Wistar Kyoto rat models of ADHD exhibit sub-regional differences in dopamine release and uptake in the striatum and nucleus accumbens.

Authors:  Erin M Miller; Francois Pomerleau; Peter Huettl; Vivienne A Russell; Greg A Gerhardt; Paul E A Glaser
Journal:  Neuropharmacology       Date:  2012-09-01       Impact factor: 5.250

7.  Histological studies of the effects of chronic implantation of ceramic-based microelectrode arrays and microdialysis probes in rat prefrontal cortex.

Authors:  Erin R Hascup; Sara af Bjerkén; Kevin N Hascup; Francois Pomerleau; Peter Huettl; Ingrid Strömberg; Greg A Gerhardt
Journal:  Brain Res       Date:  2009-07-03       Impact factor: 3.252

Review 8.  Context-dependent dynamic processes in attention deficit/hyperactivity disorder: differentiating common and unique effects of state regulation deficits and delay aversion.

Authors:  Edmund J S Sonuga-Barke; Jan R Wiersema; Jacob J van der Meere; Herbert Roeyers
Journal:  Neuropsychol Rev       Date:  2009-09-15       Impact factor: 7.444

9.  Amphetamine paradoxically augments exocytotic dopamine release and phasic dopamine signals.

Authors:  D P Daberkow; H D Brown; K D Bunner; S A Kraniotis; M A Doellman; M E Ragozzino; P A Garris; M F Roitman
Journal:  J Neurosci       Date:  2013-01-09       Impact factor: 6.167

10.  Attention-deficit hyperactivity disorder: recent advances in paediatric pharmacotherapy.

Authors:  Diane E May; Christopher J Kratochvil
Journal:  Drugs       Date:  2010       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.